HIV prevention, treatment, care, and other support services rely heavily on HIV diagnostics. Along with HIV self-testing, the diagnosis of HIV includes testing services in healthcare facilities, standalone locations, and a variety of community-based approaches. New and significant opportunities for addressing HIV among men who have sex with men are presented by developments like home testing (MSM). In 2017, there were approximately 5.2 million HIV-positive people living in Asia and the Pacific, according to data from UNAIDS, the Joint United Nations Program on HIV and AIDS, 2018.
Test
ELISA Enzyme-linked immunosorbent assay, or ELISA, is used to find HIV Diagnostics Market infection. The
Western blot test is typically used to confirm the diagnosis after an ELISA
test is positive.
To track viral load in patients receiving ART, high
usage of viral load tests is frequently carried out. Modern point-of-care
molecular testing allows these tests to be carried out outside of laboratories.
Segment demand will also be fueled by a strong product lineup and the presence
of major industry players in the sector.
ELISA
Test HIV Diagnostics Market is identified
using the ELISA, or enzyme-linked immunosorbent assay, method. Normally, the
Western blot test is used to confirm the diagnosis after an ELISA test is
positive.
To track viral load in patients receiving ART, viral
load tests are frequently administered. Modern point-of-care molecular testing
makes it possible to carry out these tests outside of a lab. Demand for the
segment will also be fueled by a strong product line and the presence of major
industry players.
One
of the major issues affecting public health today is HIV
Diagnostics Market. If HIV is not
treated in a timely manner, AIDS may develop. There is still no vaccine or
preventive treatment to stop the spread of the infection, despite extensive
research and advancements in the field of HIV science. One of the only ways to
combat an infectious disease is to treat it quickly and give the patient access
to quality medical care.
As a result, numerous governments, nongovernmental
organizations, and other organizations play a critical role in raising
awareness of HIV/AIDS prevention. Numerous programs are being implemented by
governments all over the world to inform the public about prevention and safer
sex practices. To deliver sophisticated patient care and management, they are
creating better healthcare infrastructure.
HIV Diagnostics Market in the Asia Pacific - Competitive
Environment
Abbott Laboratories, Merck KGaA, F. Hoffmann-La Roche AG, Atomo Diagnostics, Siemens Healthineers, Inc., bioLytical Laboratories Inc., MedMira Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., and Danaher Corporation are important market participants in the Asia Pacific HIV diagnostics market.
Comments
Post a Comment